Amgen Inc (AMGN) insider trading

Every open-market stock purchase and sale by Amgen Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Healthcare.

Insider activity at a glance

  • Derek Miller (VP) and 2 others sold $4.1M in the last 90 days.
  • Last insider buy: Fred Hassan (Director), $500K, 11 years ago.
  • Congress: David J. Taylor bought $1K to $15K, 4 weeks ago.

Last 12 months: insiders bought $0 (0 buys) and sold $29.3M (9 sales). Last close $438.34 on Oct 21, 2026.

Recent AMGN insider trades

DateInsiderTradeValue
Sep 22, 2026David J. Taylor (Representative)Bought$1K–15K
Aug 26, 2026David J. Taylor (Representative)Sold$1K–15K
Aug 26, 2026David J. Taylor (Representative)Sold$1K–15K
Aug 13, 2026Rachna Khosla (VP)Sold$521K
Aug 13, 2026Rachna Khosla (VP)Bought (not open market)—
Aug 12, 2026Sheldon Whitehouse (Senator)Sold$1K–15K
Aug 11, 2026Rachna Khosla (VP)Sold$825K
Aug 7, 2026Matthew C. Busch (C-suite exec)Bought (not open market)—
Aug 7, 2026Omar Ishrak (Director)Bought (not open market)—
Aug 7, 2026Charles M Holley (Director)Bought (not open market)—
Aug 7, 2026Michael V Drake (Director)Bought (not open market)—
Aug 6, 2026Derek Miller (VP)Sold$833K
Aug 6, 2026Nancy A. Grygiel (C-suite exec)Sold$792K
Aug 6, 2026Derek Miller (VP)Sold$733K
Aug 6, 2026Nancy A. Grygiel (C-suite exec)Sold$402K
Aug 6, 2026Nancy A. Grygiel (C-suite exec)Bought (not open market)—
Aug 6, 2026Derek Miller (VP)Bought (not open market)—
Aug 6, 2026Derek Miller (VP)Bought (not open market)—
Aug 6, 2026Nancy A. Grygiel (C-suite exec)Bought (not open market)—
Jun 5, 2026David J. Taylor (Representative)Bought$1K–15K
May 19, 2026Tyler Jacks (Director)Bought (not open market)—
May 19, 2026Michael V Drake (Director)Bought (not open market)—
May 19, 2026Brian Druker (Director)Bought (not open market)—
May 19, 2026Robert Eckert (Director)Bought (not open market)—
May 19, 2026Greg C. Garland (Director)Bought (not open market)—

Who's trading AMGN

Get free alerts when an insider at Amgen Inc files a new trade →